Charles river to perform plasmid production for ship of theseus

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) and ship of theseus, a therapeutics company developing degradation-resistant homeobox (hox) family biologics, today announced a good manufacturing practice- (gmp) plasmid dna contract development and manufacturing organization (cdmo) agreement. ship of theseus will leverage charles river's premier expertise to manufacture gmp plasmid dna to serve as the active drug substance for its lead candidate. sh.
CRL Ratings Summary
CRL Quant Ranking